ENBIO Co., Ltd. (KOSDAQ:352940)

ENBIO Statistics

Total Valuation

ENBIO has a market cap or net worth of KRW 23.04 billion. The enterprise value is 32.12 billion.

Market Cap	23.04B
Enterprise Value	32.12B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

ENBIO has 10.87 million shares outstanding. The number of shares has decreased by -1.02% in one year.

Current Share Class	10.87M
Shares Outstanding	10.87M
Shares Change (YoY)	-1.02%
Shares Change (QoQ)	-1.34%
Owned by Insiders (%)	38.63%
Owned by Institutions (%)	n/a
Float	6.67M

Valuation Ratios

The trailing PE ratio is 22.80.

PE Ratio	22.80
Forward PE	n/a
PS Ratio	0.68
PB Ratio	0.54
P/TBV Ratio	0.54
P/FCF Ratio	10.16
P/OCF Ratio	2.54
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.53, with an EV/FCF ratio of 14.17.

EV / Earnings	31.88
EV / Sales	0.95
EV / EBITDA	12.53
EV / EBIT	35.01
EV / FCF	14.17

Financial Position

The company has a current ratio of 1.68, with a Debt / Equity ratio of 0.33.

Current Ratio	1.68
Quick Ratio	0.83
Debt / Equity	0.33
Debt / EBITDA	5.48
Debt / FCF	6.20
Interest Coverage	1.51

Financial Efficiency

Return on equity (ROE) is 2.41% and return on invested capital (ROIC) is 1.44%.

Return on Equity (ROE)	2.41%
Return on Assets (ROA)	0.84%
Return on Invested Capital (ROIC)	1.44%
Return on Capital Employed (ROCE)	1.93%
Weighted Average Cost of Capital (WACC)	6.75%
Revenue Per Employee	424.41M
Profits Per Employee	12.59M
Employee Count	80
Asset Turnover	0.50
Inventory Turnover	1.31

Taxes

In the past 12 months, ENBIO has paid 193.30 million in taxes.

Income Tax	193.30M
Effective Tax Rate	16.10%

Stock Price Statistics

The stock price has decreased by -0.70% in the last 52 weeks. The beta is 0.80, so ENBIO's price volatility has been lower than the market average.

Beta (5Y)	0.80
52-Week Price Change	-0.70%
50-Day Moving Average	2,086.74
200-Day Moving Average	2,274.84
Relative Strength Index (RSI)	57.20
Average Volume (20 Days)	21,548

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ENBIO had revenue of KRW 33.95 billion and earned 1.01 billion in profits. Earnings per share was 93.00.

Revenue	33.95B
Gross Profit	11.60B
Operating Income	917.42M
Pretax Income	1.20B
Net Income	1.01B
EBITDA	2.56B
EBIT	917.42M
Earnings Per Share (EPS)	93.00

Balance Sheet

The company has 4.98 billion in cash and 14.06 billion in debt, with a net cash position of -9.08 billion or -835.24 per share.

Cash & Cash Equivalents	4.98B
Total Debt	14.06B
Net Cash	-9.08B
Net Cash Per Share	-835.24
Equity (Book Value)	42.36B
Book Value Per Share	3,950.61
Working Capital	14.60B

Cash Flow

In the last 12 months, operating cash flow was 9.09 billion and capital expenditures -6.82 billion, giving a free cash flow of 2.27 billion.

Operating Cash Flow	9.09B
Capital Expenditures	-6.82B
Depreciation & Amortization	1.65B
Net Borrowing	-1.23B
Free Cash Flow	2.27B
FCF Per Share	208.58

Margins

Gross margin is 34.16%, with operating and profit margins of 2.70% and 2.97%.

Gross Margin	34.16%
Operating Margin	2.70%
Pretax Margin	3.54%
Profit Margin	2.97%
EBITDA Margin	7.55%
EBIT Margin	2.70%
FCF Margin	6.68%

Dividends & Yields

ENBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.02%
Shareholder Yield	1.02%
Earnings Yield	4.37%
FCF Yield	9.84%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ENBIO has an Altman Z-Score of 1.14 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.14
Piotroski F-Score	5